Terms: = Lymphoma AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
4446 results:
1. Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy.
Kwak K; Park Y; Kim BS; Kang KW
Sci Rep; 2024 May; 14(1):11229. PubMed ID: 38755279
[TBL] [Abstract] [Full Text] [Related]
2. Primary colon lymphomas: An analysis of our experience over the last 18 years.
Hasturk D; Akturk Esen S; Buyukaksoy M; Civelek B; Seven I; Uncu D
Medicine (Baltimore); 2024 May; 103(19):e38013. PubMed ID: 38728507
[TBL] [Abstract] [Full Text] [Related]
3. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and Prognosis of Non-Hodgkin's lymphoma].
Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
[TBL] [Abstract] [Full Text] [Related]
4. Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.
Liu W; Liu W; Zou H; Chen L; Huang W; Lv R; Xu Y; Liu H; Shi Y; Wang K; Wang Y; Xiong W; Deng S; Yi S; Sui W; Peng G; Ma Y; Wang H; Lv L; Wang J; Wei J; Qiu L; Zheng W; Zou D
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631712
[TBL] [Abstract] [Full Text] [Related]
5. Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.
Edahiro Y; Ochiai T; Hashimoto Y; Ichii M; Okatani T; Omura H; Nakajima K; Sasaki M; Ando J; Takaku T; Koike M; Izumiyama K; Hiraga J; Yano T; Usuki K; Ohtsuka E; Yokoyama K; Oyake T; Takahashi N; Nishida T; Nakao T; Fukuda Y; Akasaka T; Mugitani A; Ando M; Komatsu N
Hematology; 2024 Dec; 29(1):2340149. PubMed ID: 38626148
[TBL] [Abstract] [Full Text] [Related]
6. Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Oporto Espuelas M; Burridge S; Kirkwood AA; Bonney D; Watts K; Shenton G; Jalowiec KA; O'Reilly MA; Roddie C; Castleton A; Clesham K; Nicholson E; Alajangi R; Prabhu S; George L; Uttenthal B; Gabelli M; Neill L; Besley C; Chaganti S; Wynn RF; Bartram J; Chiesa R; Lucchini G; Pavasovic V; Rao A; Rao K; Silva J; Samarasinghe S; Vora A; Clark P; Cummins M; Marks DI; Amrolia P; Hough R; Ghorashian S
Blood Cancer J; 2024 Apr; 14(1):66. PubMed ID: 38622139
[TBL] [Abstract] [Full Text] [Related]
7. How does deep learning/machine learning perform in comparison to radiologists in distinguishing glioblastomas (or grade IV astrocytomas) from primary CNS lymphomas?: a meta-analysis and systematic review.
Guha A; Halder S; Shinde SH; Gawde J; Munnolli S; Talole S; Goda JS
Clin Radiol; 2024 Jun; 79(6):460-472. PubMed ID: 38614870
[TBL] [Abstract] [Full Text] [Related]
8. Low-molecular-weight fucoidan increases telomere length and immunostimulatory effects on NK-92 cells following inhaled anesthetic injury.
Chang CH; Hwang PA
Mutat Res; 2024; 828():111857. PubMed ID: 38603928
[TBL] [Abstract] [Full Text] [Related]
9. High yield killing of lymphoma cells by anti-CD22 CAR-NK cell therapy.
Abbaszade Dibavar M; Soleimani M; Mohammadi MH; Zomorrod MS
In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):321-332. PubMed ID: 38589736
[TBL] [Abstract] [Full Text] [Related]
10. Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study.
Takahashi M; Kondo S; Kagawa K; Nakamura M; Maeda Y; Sumitani R; Yagi H; Oura M; Sogabe K; Harada T; Fujii S; Miki H; Endo I; Abe M; Nakamura S
BMJ Support Palliat Care; 2024 May; 14(2):195-199. PubMed ID: 38569748
[TBL] [Abstract] [Full Text] [Related]
11. Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials.
Lund JL; Cacciatore J; Tylock R; Su IH; Sharma S; Hinton SP; Smith S; Nowels MA; Chen X; Duberstein PR; Hanson LC; Mohile SG
JCO Clin Cancer Inform; 2024 Apr; 8():e2300183. PubMed ID: 38564692
[TBL] [Abstract] [Full Text] [Related]
12. [Safety and efficacy of donor-derived chimeric antigen receptor T-cell therapy in patients with relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Zhuo YQ; Tu SF; Zhou X; Yang JL; Zhou LJ; Huang R; Huang YX; Li MF; Jin B; Wang B; Li SQ; Yuan ZT; Zhang LH; Liu L; Wang SB; Li YH
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):74-81. PubMed ID: 38527842
[No Abstract] [Full Text] [Related]
13. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Fertility and Forecasting Collaborators
Lancet; 2024 May; 403(10440):2057-2099. PubMed ID: 38521087
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing.
Jeon MJ; Yu ES; Kim DS; Choi CW; Kim HN; Kwon JA; Yoon SY; Yoon J
J Clin Lab Anal; 2024 Mar; 38(6):e25027. PubMed ID: 38506403
[TBL] [Abstract] [Full Text] [Related]
15. Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.
Melchior L; Hirschmann A; Hofman P; Bontoux C; Concha A; Mrabet-Dahbi S; Vannuffel P; Watkin E; Putzová M; Scarpino S; Cayre A; Martin P; Stoehr R; Hartmann A
Virchows Arch; 2024 Apr; 484(4):677-686. PubMed ID: 38492039
[TBL] [Abstract] [Full Text] [Related]
16. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy.
Choi W; Jia Y; Kwak J; Werner-Wasik M; Dicker AP; Simone NL; Storozynsky E; Jain V; Vinogradskiy Y
JCO Clin Cancer Inform; 2024 Mar; 8():e2300241. PubMed ID: 38452302
[TBL] [Abstract] [Full Text] [Related]
17. Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.
Nguyen Y; Nocturne G; Henry J; Ng WF; Belkhir R; Desmoulins F; Bergé E; Morel J; Perdriger A; Dernis E; Devauchelle-Pensec V; Sène D; Dieudé P; Couderc M; Fauchais AL; Larroche C; Vittecoq O; Salliot C; Hachulla E; Le Guern V; Gottenberg JE; Mariette X; Seror R
Lancet Rheumatol; 2024 Apr; 6(4):e216-e225. PubMed ID: 38437852
[TBL] [Abstract] [Full Text] [Related]
18. Long-term monitoring of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the MALT1 gene.
Iwamuro M; Takenaka R; Miyahara K; Okanoue S; Yoshioka M; Sakaguchi C; Yamamoto K; Kawai Y; Toyokawa T; Tanaka T; Otsuka M
Sci Rep; 2024 Feb; 14(1):4953. PubMed ID: 38418651
[TBL] [Abstract] [Full Text] [Related]
19. Influence of Minimal Residual Disease at Day 15 of Induction Therapy on Survival of Children with Acute Lymphoblastic Leukemia.
Samardžić-Predojević J; Đurđević-Banjac B; Malčić-Zanić D
Acta Med Acad; 2023 Dec; 52(3):153-160. PubMed ID: 38407081
[TBL] [Abstract] [Full Text] [Related]
20. COVID-19 in Pediatric Patients With Acute Lymphoblastic Leukemia or lymphoma.
Hashmi SK; Bodea J; Patni T; Angel S; Bhakta NH; Jeha S; Karol SE; Ribeiro RC; Rubnitz JE; Wolf J; Li Y; Pui CH; Hijano DR; Inaba H
JAMA Netw Open; 2024 Feb; 7(2):e2355727. PubMed ID: 38363571
[TBL] [Abstract] [Full Text] [Related]
[Next]